Literature DB >> 8211867

Factors of importance for the long term prognosis after hospital treated pneumonia.

J U Hedlund1, A B Ortqvist, M E Kalin, F Granath.   

Abstract

BACKGROUND: Elderly patients admitted to hospital for community acquired pneumonia have a high risk of recurrence of pneumonia and of death during the years after discharge. In this study potential factors of importance for the long term prognosis after hospital treated pneumonia were retrospectively investigated.
METHODS: A total of 241 patients (103 men) with a mean age of 60 (range 18-102) years discharged from hospital after treatment for community acquired pneumonia were studied. After an average follow up period of 31 months, 18 independent variables present during hospital treatment of the initial pneumonia were examined for association with the following end points: recurrence of pneumonia, death from any cause, and death from pneumonia.
RESULTS: Age adjusted analysis showed that systemic treatment with corticosteroids correlated significantly with recurrence of pneumonia and with death. The presence of low serum albumin levels on admission or colonisation of the respiratory tract with Gram negative enteric bacteria seemed to be important negative prognostic factors for the outcome during pneumonia recurrences after discharge.
CONCLUSIONS: Patients who are admitted to hospital with pneumonia are at risk of subsequent pneumonia and death after discharge. This risk seems to be even higher in patients who are treated with corticosteroids systemically, who have a low serum albumin level on admission, or who become colonised in the respiratory tract with Gram negative enteric bacteria during their hospital stay.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8211867      PMCID: PMC464701          DOI: 10.1136/thx.48.8.785

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  21 in total

1.  Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization.

Authors:  A Ortqvist; J Hedlund; L Grillner; E Jalonen; I Kallings; M Leinonen; M Kalin
Journal:  Eur Respir J       Date:  1990-11       Impact factor: 16.671

2.  Respiratory tract colonization and incidence of secondary infection during hospital treatment of community-acquired pneumonia.

Authors:  A Ortqvist; S Hammers-Berggren; M Kalin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

3.  Dietary supplementation in elderly patients with fractured neck of the femur.

Authors:  M Delmi; C H Rapin; J M Bengoa; P D Delmas; H Vasey; J P Bonjour
Journal:  Lancet       Date:  1990-04-28       Impact factor: 79.321

4.  Serum albumin level on admission as a predictor of death, length of stay, and readmission.

Authors:  F R Herrmann; C Safran; S E Levkoff; K L Minaker
Journal:  Arch Intern Med       Date:  1992-01

5.  A prognostic inflammatory and nutritional index scoring critically ill patients.

Authors:  Y Ingenbleek; Y A Carpentier
Journal:  Int J Vitam Nutr Res       Date:  1985       Impact factor: 1.784

6.  Failure of intensive care unit support to influence mortality from pneumococcal bacteremia.

Authors:  E W Hook; C A Horton; D R Schaberg
Journal:  JAMA       Date:  1983-02-25       Impact factor: 56.272

7.  Pneumonia due to Mycoplasma pneumoniae. Its incidence in the membership of a co-operative medical group.

Authors:  E R Alexander; H M Foy; G E Kenny; R A Kronmal; R McMahan; E R Clarke; W A MacColl; J T Grayston
Journal:  N Engl J Med       Date:  1966-07-21       Impact factor: 91.245

8.  A hospital study of community acquired pneumonia in the elderly.

Authors:  P Venkatesan; J Gladman; J T Macfarlane; D Barer; P Berman; W Kinnear; R G Finch
Journal:  Thorax       Date:  1990-04       Impact factor: 9.139

9.  Long-term epidemiology of infections with Mycoplasma pneumoniae.

Authors:  H M Foy; G E Kenny; M K Cooney; I D Allan
Journal:  J Infect Dis       Date:  1979-06       Impact factor: 5.226

10.  Community-acquired pneumonia requiring hospitalization: 5-year prospective study.

Authors:  T J Marrie; H Durant; L Yates
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug
View more
  17 in total

1.  Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis.

Authors:  Sachin Yende; Gina D'Angelo; John A Kellum; Lisa Weissfeld; Jonathan Fine; Robert D Welch; Lan Kong; Melinda Carter; Derek C Angus
Journal:  Am J Respir Crit Care Med       Date:  2008-03-27       Impact factor: 21.405

2.  Pseudomonas aeruginosa infection liberates transmissible, cytotoxic prion amyloids.

Authors:  Ron Balczon; K Adam Morrow; Chun Zhou; Bradley Edmonds; Mikhail Alexeyev; Jean-Francois Pittet; Brant M Wagener; Stephen A Moser; Silas Leavesley; Xiangming Zha; Dara W Frank; Troy Stevens
Journal:  FASEB J       Date:  2017-03-17       Impact factor: 5.191

3.  Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa.

Authors:  Ron Balczon; Michael Francis; Silas Leavesley; Troy Stevens
Journal:  J Vis Exp       Date:  2018-07-12       Impact factor: 1.355

Review 4.  Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality.

Authors:  T Welte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

Review 5.  Long-term prognosis in community-acquired pneumonia.

Authors:  Marcos I Restrepo; Paola Faverio; Antonio Anzueto
Journal:  Curr Opin Infect Dis       Date:  2013-04       Impact factor: 4.915

6.  Pharmacotherapy and the risk for community-acquired pneumonia.

Authors:  Jen-Tzer Gau; Utkarsh Acharya; Salman Khan; Victor Heh; Lona Mody; Tzu-Cheg Kao
Journal:  BMC Geriatr       Date:  2010-07-06       Impact factor: 3.921

7.  Long-term survival after hospitalization for community-acquired and healthcare-associated pneumonia.

Authors:  Laura M Cecere; Gordon D Rubenfeld; David R Park; Richard K Root; Christopher H Goss
Journal:  Respiration       Date:  2009-11-04       Impact factor: 3.580

8.  Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia?

Authors:  Marco Confalonieri; Djillali Annane; Caterina Antonaglia; Mario Santagiuliana; Ediva M Borriello; G Umberto Meduri
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

9.  Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths.

Authors:  Sachin Yende; Gina D'Angelo; Florian Mayr; John A Kellum; Lisa Weissfeld; A Murat Kaynar; Tammy Young; Kaikobad Irani; Derek C Angus
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

10.  C-reactive protein/albumin ratio predicts 90-day mortality of septic patients.

Authors:  Otavio T Ranzani; Fernando Godinho Zampieri; Daniel Neves Forte; Luciano Cesar Pontes Azevedo; Marcelo Park
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.